JP2008512395A5 - - Google Patents

Download PDF

Info

Publication number
JP2008512395A5
JP2008512395A5 JP2007530547A JP2007530547A JP2008512395A5 JP 2008512395 A5 JP2008512395 A5 JP 2008512395A5 JP 2007530547 A JP2007530547 A JP 2007530547A JP 2007530547 A JP2007530547 A JP 2007530547A JP 2008512395 A5 JP2008512395 A5 JP 2008512395A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
aryl
hydrogen
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007530547A
Other languages
English (en)
Japanese (ja)
Other versions
JP5031567B2 (ja
JP2008512395A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2005/001380 external-priority patent/WO2006026832A1/en
Publication of JP2008512395A publication Critical patent/JP2008512395A/ja
Publication of JP2008512395A5 publication Critical patent/JP2008512395A5/ja
Application granted granted Critical
Publication of JP5031567B2 publication Critical patent/JP5031567B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007530547A 2004-09-09 2005-09-09 酵素阻害剤およびその使用 Expired - Fee Related JP5031567B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2004905182 2004-09-09
AU2004905182A AU2004905182A0 (en) 2004-09-09 Enzyme inhibitors and uses thereof
PCT/AU2005/001380 WO2006026832A1 (en) 2004-09-09 2005-09-09 Enzyme inhibitors and uses thereof

Publications (3)

Publication Number Publication Date
JP2008512395A JP2008512395A (ja) 2008-04-24
JP2008512395A5 true JP2008512395A5 (cg-RX-API-DMAC7.html) 2008-10-23
JP5031567B2 JP5031567B2 (ja) 2012-09-19

Family

ID=36036029

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007530547A Expired - Fee Related JP5031567B2 (ja) 2004-09-09 2005-09-09 酵素阻害剤およびその使用

Country Status (13)

Country Link
US (1) US20080194636A1 (cg-RX-API-DMAC7.html)
EP (1) EP1789079B1 (cg-RX-API-DMAC7.html)
JP (1) JP5031567B2 (cg-RX-API-DMAC7.html)
KR (1) KR20070100878A (cg-RX-API-DMAC7.html)
CN (1) CN101039690A (cg-RX-API-DMAC7.html)
CA (1) CA2579768A1 (cg-RX-API-DMAC7.html)
DK (1) DK1789079T3 (cg-RX-API-DMAC7.html)
ES (1) ES2403340T3 (cg-RX-API-DMAC7.html)
IL (1) IL181819A (cg-RX-API-DMAC7.html)
NZ (1) NZ553688A (cg-RX-API-DMAC7.html)
SG (1) SG155901A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006026832A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200702041B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263775B2 (en) 2007-11-19 2012-09-11 Howard Florey Institute Insulin-regulated aminopeptidase (IRAP) inhibitors and uses thereof
CN101284820B (zh) * 2008-04-25 2011-05-04 南昌大学 一种氨肽酶抑制剂及合成方法
CN103848805A (zh) * 2012-12-06 2014-06-11 韩冰 一类治疗神经退行性疾病的化合物及其用途
CN103896900A (zh) * 2012-12-25 2014-07-02 韩冰 一类具有神经保护作用的化合物及其制备方法和用途
PL3150581T3 (pl) 2014-05-28 2020-07-13 Astellas Pharma Inc. Pochodne pirydyny
AR102849A1 (es) 2015-03-09 2017-03-29 Astellas Pharma Inc Compuesto de piridina bicíclica
WO2017015720A1 (en) 2015-07-30 2017-02-02 Monash University Fibrotic treatment
WO2023099589A1 (en) 2021-12-01 2023-06-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Irap inhibitors for use in the treatment of inflammatory diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284868A (en) * 1991-10-09 1994-02-08 Eli Lilly And Company Pharmaceutical compounds
US5281619A (en) 1992-09-25 1994-01-25 Eli Lilly And Company Therapy for diabetic complications
EP1004584A3 (en) 1992-11-18 2000-07-05 Eli Lilly And Company Limited Pyranoquinoline derivatives as inhibitors of cell proliferation
US6680332B1 (en) * 1999-06-04 2004-01-20 Euro-Celtique S.A. Substituted 5-oxo-5,6,7,8-tetrahydro-4H-1-benzopyrans and benzothiopyrans and the use thereof as potentiators of AMPA
EP1392683B1 (en) * 2001-05-16 2009-12-02 Cytovia, Inc. Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and their use as anticancer agents
US20050020519A1 (en) * 2001-08-02 2005-01-27 Albiston Anthony L. Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity
US20030114418A1 (en) * 2001-08-14 2003-06-19 Pharmacia Corporation Method for the treatment and prevention of pain and inflammation with glucosamine and a cyclooxygenase-2 selective inhibitor and compositions therefor
PL372488A1 (en) * 2002-02-13 2005-07-25 F.Hoffmann-La Roche Ag Novel pyridine- and quinoline-derivatives
US8263775B2 (en) * 2007-11-19 2012-09-11 Howard Florey Institute Insulin-regulated aminopeptidase (IRAP) inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
US10905701B2 (en) Compositions and methods for inhibiting arginase activity
US10676472B2 (en) Crystal forms of glutaminase inhibitors
US10793535B2 (en) Heterocyclic glutaminase inhibitors
CN107027291B (zh) 用谷氨酰胺酶抑制剂的组合疗法
ES2243441T3 (es) Derivados de imidazolio fundidos.
US20160324829A1 (en) Combination therapy with parp inhibitors
US10278968B2 (en) Combination therapy with glutaminase inhibitors
AU2013344560A1 (en) Heterocyclic glutaminase inhibitors
JP2019504113A (ja) 痛覚過敏を治療する方法
US20160200697A1 (en) Inhibition of wnt, tgf beta and hippo signaling pathways to treat cancer, organ fibrosis and metabolic disorders
KR20120055692A (ko) 화학요법에 의해 유도되는 통증의 예방 또는 치료를 위한 시그마 리간드
CN101534835A (zh) 用于癌症的L-OddC的前药
US20130225647A1 (en) Combination therapy with parp inhibitors
WO2014201111A1 (en) Treatment of mtor hyperactive related diseases and disorders
KR20140043900A (ko) Ape1 매개된 질환을 치료하기 위한 퀴논 화합물
JP2026506429A (ja) Mta協同的prmt5阻害薬を使用した癌治療
US9205091B2 (en) Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
JP2018527330A5 (cg-RX-API-DMAC7.html)
AU2020402994A1 (en) Methods of treating cancer
JP2017515899A (ja) カンナビノイド受容体メディエータとしてのピラゾール誘導体およびそれらの使用
US20190247397A1 (en) Combinatory treatment strategies of cancer based on rna polymerase i inhibition
US20070004777A1 (en) Methods for treating or preventing acute myelogenous leukemia
JP5830983B2 (ja) 抗癌剤の副作用軽減剤
JP2010526073A (ja) 癌または前癌性症状およびその他の症状の治療のためのジヒドロピリジン誘導体
ES2898072T3 (es) Métodos para tratar el cáncer de ovario